Cochlear Implant Atlas
CI Atlas · History of the Cochlear Implant · Module 08

8The European devices — Chouard & MED-EL

The cochlear implant is sometimes told as an American–Australian story, but Europe was there from the start, and one of the three manufacturers that dominate the world market today is European. In Paris, the surgeon Claude-Henri Chouard built an early multichannel device in the 1970s, picking up the thread the French had begun with Djourno and Eyriès. In Vienna, Ingeborg and Erwin Hochmair developed a multichannel implant — including pioneering long, flexible electrode arrays — that grew into MED-EL, now a global leader. This module completes the cast of the multichannel era and traces how today's manufacturers descend from these separate beginnings.

FEurope in the multichannel race

Having given the field its very origin (Djourno and Eyriès, Module 3), France and the wider European scene stayed in the contest. Through the 1970s and 1980s, European groups built multichannel devices in parallel with the Australian and American efforts — and one of them produced a company that is, today, among the largest cochlear-implant manufacturers in the world.

CChouard in Paris

Claude-Henri Chouard, a French ear surgeon, developed a multichannel cochlear implant in Paris in the 1970s, consciously continuing the French line of work. His device demonstrated that the multichannel approach was being pursued seriously on several continents at once. As a commercial product the French device did not ultimately survive into the modern market, but it is an important part of the historical record and a reminder that the multichannel idea had broad independent support.

CThe Hochmairs and MED-EL

In Vienna, the engineers Ingeborg Hochmair and Erwin Hochmair developed a multichannel cochlear implant beginning in the late 1970s. Their work was notable for pursuing long, flexible electrode arrays intended to reach further along the cochlea and cover more of its frequency range. Their device grew into the company MED-EL, now one of the major global manufacturers. Ingeborg Hochmair's contribution was later recognised with a share of the 2013 Lasker Award (Module 13).[2013]

Long vs short arrays — how much of the cochlea to cover

base · high frequencyapex · low frequencyLong, flexible array (MED-EL lineage)Shorter arrayLonger = deeper insertion, more low-frequency coverageTrade-off: deeper insertion vs gentler, hearing-preserving surgery

The European program left a lasting technical signature. The Hochmairs pursued long, flexible arrays intended to insert further toward the apex and cover more of the cochlea's low-frequency range, where shorter arrays reach mainly the basal, high-frequency turn. There is a genuine trade-off — deeper coverage versus the gentler insertion that preserves residual hearing — and different manufacturers still make different choices. It is one reason device selection is not interchangeable. Schematic, not exact depths.

FTThe surviving manufacturers

It is worth seeing how the pioneering programs map onto the devices a clinician encounters today. Three manufacturers dominate the modern market, and each descends from a distinct historical lineage — Australian, Austrian, and American.

Where the implants came from — manufacturers & their origins

Cochlear (Nucleus)
Australia
Graeme Clark, Melbourne
MED-EL
Austria
Ingeborg & Erwin Hochmair, Vienna
Advanced Bionics
USA
UCSF / Clarion lineage
Chouard / Bertin device
France
Claude-Henri Chouard, Paris · historical
Ineraid (Symbion)
USA
Utah (Eddington et al.) · historical

The modern market traces to a handful of pioneering programs. Cochlear grew from Clark's Melbourne work, MED-EL from the Hochmairs in Vienna (whose early multichannel device dates to the late 1970s), and Advanced Bionics from the UCSF/Clarion line. Europe's contribution was central — alongside MED-EL, the French surgeon Chouard built an early multichannel device — even where, as with Chouard's device and the US Ineraid, the specific product did not survive as an independent brand.

CA field of competitors

The survival of several independent manufacturers, descended from separate research programs, has shaped the modern field in a concrete way: it created competition in electrode design, coding strategy and processor engineering that has driven steady improvement. The device-specific differences a programming audiologist navigates today (covered in the Objective Measures chapter) are the living trace of these distinct origins.

We have now assembled the hardware and the players. But multichannel devices in the early-to-mid 1980s still gave only modest speech results. The transformation — the single most important advance in the implant's performance — came not from new electrodes but from a new way of coding sound: the speech-coding breakthrough (Module 9).

Case 1.8 · Placing the manufacturers
A new audiologist asks where the three implant brands your programme uses actually came from, having heard the implant called 'an Australian invention'.

Which statement is historically accurate?

Self-assessment — Module 82 questions
Question 1 · Foundation

Which major modern manufacturer grew from the Hochmairs' work in Vienna?

Question 2 · Trainee

What is true of the French contribution to the cochlear implant?

Tracked locally in your browser — see /progress for the dashboard.